Squarepoint’s Dermira, Inc. DERM Stock Holding History

Squarepoint’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-132,663	Closed	-$2.01M	–	2829
2019 Q4	$2.01M	Sell	132,663 -46,069	-26%	-$398K	0.01%	907
2019 Q3	$1.14M	Buy	178,732 +19,480	+12%	+$163K	0.01%	1139
2019 Q2	$1.52M	Buy	159,252 +146,385	+1,138%	+$1.58M	0.01%	1002
2019 Q1	$174K	Sell	12,867 -35,389	-73%	-$295K	﹤0.01%	1966
2018 Q4	$347K	Buy	+48,256	New	+$528K	﹤0.01%	1432
2018 Q3	–	Sell	-23,180	Closed	-$213K	–	2341
2018 Q2	$213K	Sell	23,180 -65,979	-74%	-$615K	﹤0.01%	1520
2018 Q1	$712K	Buy	89,159 +70,701	+383%	+$1.54M	0.01%	945
2017 Q4	$513K	Buy	+18,458	New	+$489K	0.01%	1198

Squarepoint's DERM Position: Q1 2020 in Review

Squarepoint sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 132,663 shares — an estimated $2.01M sold.

Squarepoint first reported a position in DERM in Q4 2017 and held it in 8 quarters. The position peaked at $2.01M in Q4 2019. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

Squarepoint reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
Squarepoint sold 132,663 Dermira, Inc. shares in Q1 2020, an estimated $2.01M.
Squarepoint first reported a position in Dermira, Inc. in Q4 2017 and held it in 8 quarters.
Squarepoint's Dermira, Inc. position peaked at $2.01M in Q4 2019.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Squarepoint's 13F filing for Q1 2020, filed 15 May 2020.